Imatinib-resistant BCR/ABL-positive KCL22/SR CML cells exhibited suppressed MYB levels in contrast to cells of the sensitive parent cell line[126]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.